However, studies have also demonstrated that DEPTOR is overexpressed in many tumours, including breast, prostate and lung cancers [43–45], indicating that DEPTOR also acts as an oncogene during tumour growth. The gene discussed is DEPTOR; the disease is lung carcinoma.